Detection of hepatitis C virus NS5 protein and genome in Chinese carcinoma of the extrahepatic bile duct and its significance

World Journal of Gastroenterology

Volumn 6, Issue 6, 2000, Pages 800-804

  Chen, M Y ^a   Huang, Z Q ^a   Chen, L Z ^a   Gao, Y B ^a   Peng, R Y ^a   Wang, D W ^a  

^a General Hospital of the Chinese PLA Beijing Region   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN; VIRUS RNA;

ARTICLE; BILE DUCT; BILE DUCT CARCINOMA; CANCER CELL; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTIOUS HEPATITIS; NONHUMAN; POLYMERASE CHAIN REACTION; RISK FACTOR; VIRUS DETECTION; VIRUS GENE; VIRUS GENOME;

EID: 0034528562     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v6.i6.800     Document Type: Article

References (67)

1. Carcinoma of the bile ducts
2. Tumours and tumour-like lesions of the liver and biliary tract
3. Primary liver cancers in Japan
4. Diagnosis and treatment of cholangiocarcinoma and cystic adenocarcinoma of the liver
5. Primary liver cancer: Angiographic study of 127 cases
6. Cholangiocarcinoma associated with liver fluke infection: A preventable source of morbidity in Asian immigrants
7. Opithorchis viverrini infection and cholangiocarcinoma: A prospective, case-controlled study
8. Biliary tumors of the liver
9. Primary malignant epithelial tumors
10. Intrahepatic cholangiocarcinoma
11. Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma
12. Present status of surgical treatment of intrahepatic lithiasis in China: A nation-wide survey of 4197 operative cases 1981 - 1985
13. Fourty-five cases of cholelithiasis with cholangiocarcinoma
14. Choice of operation in congenital dilation of the bile duct in adults
15. Cancerization of choledochal cyst in adults: Report of 12 cases
16. Analysis of five cases of bile duct cysts with bile duct carcinoma
17. Ten cases report on congenital choledochal cyst associated biliary cancer
18. The relationship between clonorchiasis (clonorchis sinensis) and other hepatobiliary diseases - Clinical analysis of 2214 cases
19. Carcinoma of extrahepatic bile duct
20. Evolution of surgical treatment of intrahepatic lithiasis in China
21. Cholangiocarcinoma as related to intrahepatic stones
22. Current progress of biliary tract surgery in China
23. The relationship between clonorchis sinensis infestion and hepatobiliary tumor
24. Analysis of 1698 cases of carcinoma of extrahepatic bile duct in China
25. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis
26. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis
27. Hepatitis C virus: Epidemiology and transmission
28. Investigation of anti-HCV in 391 serum samples in China
29. Seoepidemiological study on hepatitis C virus infection among blood donors from various regions in China
30. A cross-sectional study on HGV infection in a rural population
31. Intracellular localization of Polymerase chain reaction (PCR)-amplified hepatitis C cDNA
32. Detection of hepatitis C virus genome in formalin-fixed paraffin-embedded liver tissue by in situ reverse transcription polymerase chain reaction
33. Infection of peripheral mononuclear blood cells by hepatitis C virus
34. Detection of hepatitis C virus RNA in peripheral blood mononuclear cells of infected patients by in situ hybridization
35. Clinical significance of detection of positive and negative strands of HCV RNA in peripheral blood mononuclear cells
36. Effect of interferon in combination with ribavirin on the plus and minus strands of HCV RNA in patients with chronic hepatitis C
37. Hepatitis C virus RNA detection in serum and peripheral blood mononuclear cells of patients with hepatitis C
38. Extrahepatic manifestations of chronic viral hepatitis
39. Detection of hepatitis C virus RNA in cells with hepatocellular carcinoma and its practical significance by in situ polymerase chain reaction
40. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
41. Localization of HCV RNA and capsid protein in human hepatocellular carcinoma
42. Detecting the localization of hepatitis B and C virus in hepatocellular carcinoma by double in situ hybridization
43. Immunohistochemical detection of HCV infection in patients with hepatocellular carcinoma and other liver diseases
44. Effect of hepatitis C virus infection on expression of several cancer-associated gene products in hepatocellular carcinoma
45. Expression and significance of HCV RNA and HCV NS5 antigen in liver tissues of patients with hepatitis C
46. Expression of HBsAg, HCV-Ag and AFP in liver cirrhosis and hepatocarcinoma
47. Hepatitis C and hepatocellular carcinoma
48. Etiological studies of hepatocellular carcinoma
49. Interrelation between hepatitis C and primary hepatocellular carcinoma
50. Clinical research advances in primary liver cancer
51. HBV concomitant infection in HCV associated HCC
52. Persistence of hepatitis c virus RNA in established human hepatocellular carcinoma cell lines
53. Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C
54. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma
55. Hepatitis B X gene and hepatocellular carcinoma
56. HBx-DNA probe preparation and its application in study of hepatocarcinogenesis
57. Expression of IGF-II, p53, p21 and HBxAg in precancerous events of hepatocarcinogenesis induced by AFB1 and/ or HBV in tree shrews
58. Analysis of point mutation in site 1896 of HBV precore and its detection in the tissues and serum of HCC patients
59. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein
60. Suppression of apoptotic cell death by hepatitis C virus core protein
61. Transcriptional repression of P53 promoter by hepatitis C virus core protein
62. Translocated expression of HCV core protein inhibits apoptosis in the tissue of hepatocellular carcinoma
63. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype
64. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells
65. Effect of HCV NS3 protein on P53 protein expression in hepatocarcinogenesis
66. Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator
67. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein